Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinumAndrea Riccardo Filippi, Gabriele Simontacchi, Sofia Meregalli et al.|Radiation Oncology|2020Cited by 32
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus RadiotherapyGabriele Simontacchi, Umberto Ricardi, Andrea Riccardo Filippi et al.|International Journal of Radiation Oncology*Biology*Physics|2015Cited by 30
Post-ABVD/pre-radiotherapy<sup>18</sup>F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patientsPatrizia Ciammella, Annibale Versari, Barbara Botto et al.|British Journal of Radiology|2016Cited by 13
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphomaCristina Piva, Umberto Ricardi, Domenico Genovesi et al.|Practical Radiation Oncology|2015Cited by 12
Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana LinfomiMario Levis, Umberto Ricardi, Belinda A. Campbell et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 7